1039MO CheckMate 204: 3-year outcomes of treatment with combination nivolumab (NIVO) plus ipilimumab (IPI) for patients (pts) with active melanoma brain metastases (MBM)
Year: 2021
Type: article
Source: Annals of Oncology
Institutions: The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, Massachusetts General Hospital, University of California, San Francisco, Angeles Clinic and Research Institute, University of Michigan, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Georgetown Lombardi Comprehensive Cancer Center, University of Colorado Cancer Center, Memorial Sloan Kettering Cancer Center, Stanford University, Weill Cornell Medicine, National Institutes of Health, National Cancer Institute, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Bristol-Myers Squibb (United States), City Of Hope National Medical Center, City of Hope
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Bristol-Myers Squibb
OpenAlex ID: W3204525381